• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Lithium for Brain Health?
Research Update

Lithium for Brain Health?

January 31, 2023
Kathryn Kieran, MSN, PMHNP-BC
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Kathryn Kieran, MSN, PMHNP-BC. Ms. Kieran has no financial relationships with companies related to this material.

REVIEW OF: Chen S et al, PLoS Medicine 2022;19(3):e1003941

STUDY TYPE: Retrospective cohort study

Low-dose lithium has recently been proposed as a potential treatment for dementia, based on a couple of retrospective studies (Gerhard T et al, Br J Psychiatry 2015;207(1):46–51; Kessing LV et al, Bipolar Disord 2010;12(1):87–94). This newest study looks at evidence that standard doses of lithium might also be helpful in preventing the development of dementia.

The study compared the electronic records of 29,618 adults in the UK age 50 years and older without diagnoses of mild cognitive impairment (MCI) or dementia. The 548 patients exposed to lithium had a greater number of cardiovascular risk factors, including antipsychotic use, central vascular disease, diabetes, hyperlipidemia, hypertension, and smoking. Of those prescribed lithium, 73% had a mania/bipolar affective disorder (BPAD) diagnosis, a known risk factor for dementia, while the remaining lithium-exposed patients were diagnosed with depression.

In the lithium-exposed cohort, 9.7% of patients were diagnosed with dementia, compared to 11.2% of the unexposed cohort. The percentage of patients diagnosed with Alzheimer’s disease was significantly lower in the lithium-exposed cohort (6.8%) compared to the unexposed cohort (8.1%), whereas the percentage of vascular dementia was the same in both cohorts (2.6%). Lithium appeared to lower dementia risk for the group taking lithium for one year or less and the group taking it for more than five years (the smaller cohort of patients taking lithium for two to four years saw no benefits, likely due to a lack of statistical power). Documented serum lithium levels were 0.49–0.80 mEq/L, with a mean of 0.61 mEq/L.

Method of diagnosis, dosing, follow-up, and adherence were highly variable or unknown. Some lithium level data were missing, so patients with supratherapeutic levels may have experienced neurotoxic effects, which can mimic dementia.

Carlat Take

We all want something to offer patients with risk factors for dementia or MCI, without peddling false hope. This study suggests that lithium might delay or prevent Alzheimer’s disease in individuals with BPAD, but the real-world conditions are limited. The variables are too numerous to contain even in this careful analysis. However, it is reasonable to discuss possible advantages of lithium in terms of dementia risk with patients already taking lithium, particularly in patients who stick with lithium long term.

Geriatric Psychiatry
KEYWORDS Bipolar depression Dementia Lithium
Kathryn Kieran, MSN, PMHNP-BC

More from this author
www.thecarlatreport.com
Issue Date: January 31, 2023
SUBSCRIBE NOW
Table Of Contents
Learning Objectives, Bipolar Disorder in Older Adults, CGPR, January/February/March 2023
Mood Stabilizers for Bipolar Disorder in Older Adults: Special Considerations
New-Onset Bipolar Disorder in Older Adults
Mania in Older Adults
Pharmacological Treatment of Bipolar Disorder in Older Adults
Lithium for Brain Health?
CME Post-Test, Bipolar Disorder in Older Adults, CGPR, January/February/March 2023
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto1062975.jpg
    Geriatric Psychiatry

    How to Treat and Assess Delirium in Older Patients

    Treatment of delirium involves correction of the underlying medical disturbance. But how do we best think through potential causes?

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.